Public Health Grand Rounds at the Aspen Institute hosts a lunchtime conversation, Precision Medicine: the Promise, the Journey, the Future, with Dr. Eric Lander, President and Founding Director of the Broad Institute of MIT and Harvard.
Eric Lander is the founding director and serves as a core member of the Broad Institute of MIT and Harvard. One of the principal leaders of the Human Genome Project, he and his colleagues have a long-standing interest in applying genomics to understand the molecular basis of human physiology and disease.
Over the past 15 years, Lander and his colleagues have created many of the key tools of human genomics and have applied these tools to pioneer new ways to understand the basis of diseases, including cancer, diabetes, and inflammatory diseases. The work includes mapping and sequencing of the human, mouse, and other genomes; understanding the functional elements encoded in genomes through comparative analysis; understanding the genetic variation in the human population and its relationship to disease susceptibility; understanding the distinctive cellular signatures of diseases and of response to drugs; understanding gene regulation; and understanding the mutations underlying cancer.
